Silver Book Fact

Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.

Campbell, Claudia M, Mark S Kipnes, Bruce C Stouch, Kerrie L Brady, Margaret Kelly, William K Schmidt, Karin L Petersen, Michael C Rowbowtham, and James N Campbell. Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy. Pain. 2012; 153(9): 1815-23. http://www.ncbi.nlm.nih.gov/pubmed/22683276

Reference

Title
Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy
Publication
Pain
Publication Date
2012
Authors
Campbell, Claudia M, Mark S Kipnes, Bruce C Stouch, Kerrie L Brady, Margaret Kelly, William K Schmidt, Karin L Petersen, Michael C Rowbowtham, and James N Campbell
Volume & Issue
Volume 153, Issue 9
Pages
1815-23
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The Mayo Clinic Pain Rehabilitation Center helps people with persistent pain return to an active lifestyle and has found that among patients who finish the program, nearly 84% report greater…  
  • Understanding the role of genetics in pain mechanisms is increasing and the potential now exists to conduct genome-wide screens in model organisms to look for pain-associated genes.  
  • Researchers have discovered that some types of glial cells have a major impact on persistent neuropathic pain and that targeting these cells may result in a new class of disease…  
  • A meta-analysis of duloxetine, an anti-depressant, found a 50% reduction in pain at 12 weeks for diabetic peripheral neuropathy, and a 50% reduction in pain at 12 weeks for fibromyalgia.  
  • An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.